Liqin Lu

1.4k total citations
48 papers, 753 citations indexed

About

Liqin Lu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Liqin Lu has authored 48 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Liqin Lu's work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (6 papers) and Autophagy in Disease and Therapy (6 papers). Liqin Lu is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (6 papers) and Autophagy in Disease and Therapy (6 papers). Liqin Lu collaborates with scholars based in China, Singapore and United Kingdom. Liqin Lu's co-authors include Jianbin Zhang, Liming Wang, Jigang Wang, Zhiyong Yu, Lin Song, Guangdi Chen, Xin Sun, Han‐Ming Shen, Huiping Li and Dong Weng and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Science of The Total Environment.

In The Last Decade

Liqin Lu

42 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liqin Lu China 18 262 137 136 118 102 48 753
Mingming Wang China 20 419 1.6× 205 1.5× 241 1.8× 115 1.0× 164 1.6× 62 1.2k
M. Yamashita Japan 19 437 1.7× 75 0.5× 167 1.2× 46 0.4× 86 0.8× 57 959
Xiaozhou Zhou China 23 525 2.0× 120 0.9× 118 0.9× 59 0.5× 149 1.5× 59 1.6k
Chunwei Li China 18 324 1.2× 85 0.6× 129 0.9× 43 0.4× 132 1.3× 38 1.1k
Hongli Yan China 23 476 1.8× 211 1.5× 88 0.6× 90 0.8× 251 2.5× 72 1.3k
Zhiyi Zhang China 21 414 1.6× 92 0.7× 166 1.2× 35 0.3× 105 1.0× 88 1.3k
Xiancheng Liu China 16 360 1.4× 74 0.5× 48 0.4× 121 1.0× 155 1.5× 52 842
Junfei Wang China 18 282 1.1× 142 1.0× 70 0.5× 58 0.5× 98 1.0× 60 986
Wensheng Deng China 22 661 2.5× 207 1.5× 48 0.4× 68 0.6× 111 1.1× 80 1.5k
Yuming Zhang China 19 342 1.3× 104 0.8× 143 1.1× 74 0.6× 156 1.5× 93 1.3k

Countries citing papers authored by Liqin Lu

Since Specialization
Citations

This map shows the geographic impact of Liqin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liqin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liqin Lu more than expected).

Fields of papers citing papers by Liqin Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liqin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liqin Lu. The network helps show where Liqin Lu may publish in the future.

Co-authorship network of co-authors of Liqin Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Liqin Lu. A scholar is included among the top collaborators of Liqin Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liqin Lu. Liqin Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Jiahui, et al.. (2025). Active aliasing ESPRIT: A robust parameter estimation method for low-intervention Blade tip timing measurement. Mechanical Systems and Signal Processing. 227. 112392–112392. 3 indexed citations
2.
Wu, Shuming, Haoqi Li, Liqin Lu, et al.. (2025). Dual-Parameter Diagnosis of Gas Turbine Blade Fatigue Cracks Based on Blade Tip Timing Data. IEEE Transactions on Instrumentation and Measurement. 74. 1–12.
3.
Lu, Liqin, et al.. (2025). Knowledge, attitudes, and practices of Chinese college students towards novel psychoactive substances. BMC Public Health. 25(1). 2442–2442.
4.
Pu, Xingxiang, Jiawei Shou, Jun Chen, et al.. (2025). Anlotinib Plus Docetaxel is Promising in Advanced NSCLC Progressing on First-Line Immunotherapy: A Pooled Analysis of Two Randomized Trials. Advances in Therapy. 42(7). 3249–3264.
5.
Wu, Desheng, et al.. (2024). Air-coupled transducer tilted C-scan for delamination introduced during the manufacturing process in CFRP plates. Nondestructive Testing And Evaluation. 40(2). 770–783. 3 indexed citations
7.
Li, Fenglan, Liqin Lu, Yutong Wu, et al.. (2024). Nitrogen and Sulfur Co-doped Carbon Dots for Ratiometric Fluorometric Determination of Mercury Ions. Journal of Fluorescence. 35(8). 6347–6355. 3 indexed citations
8.
Chen, Yun, et al.. (2022). Continuous intravenous infusion of recombinant human endostatin using infusion pump plus chemotherapy in non-small cell lung cancer. World Journal of Clinical Cases. 10(4). 1164–1171. 2 indexed citations
9.
Zhang, Zhaowenbin, Dong Weng, Liqin Lu, et al.. (2021). Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics. Bioactive Materials. 6(10). 3194–3206. 26 indexed citations
10.
Fang, Yong, Hongming Pan, Jiawei Shou, et al.. (2021). Anlotinib plus docetaxel versus docetaxel as second-line treatment for advanced non-small cell lung cancer (NSCLC): Updated results from a phase I/II study.. Journal of Clinical Oncology. 39(15_suppl). e21055–e21055. 2 indexed citations
11.
Zhao, Mengmeng, Qiuhong Li, Liqin Lu, et al.. (2019). IL-17A Can Promote Propionibacterium acnes-Induced Sarcoidosis-Like Granulomatosis in Mice. Frontiers in Immunology. 10. 1923–1923. 17 indexed citations
12.
Zhang, Jianbin, Xin Sun, Liming Wang, et al.. (2018). Artesunate-induced mitophagy alters cellular redox status. Redox Biology. 19. 263–273. 66 indexed citations
13.
Weng, Dong, Qin Wu, Tao Chen, et al.. (2018). Azithromycin treats diffuse panbronchiolitis by targeting T cells via inhibition of mTOR pathway. Biomedicine & Pharmacotherapy. 110. 440–448. 18 indexed citations
14.
Qiu, Hui, Dong Weng, Li Shen, et al.. (2017). Stimulator of Interferon Genes Deficiency in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Frontiers in Immunology. 8. 1756–1756. 22 indexed citations
15.
Jin, Ying, Guangyun Mao, Yaping Wei, et al.. (2016). CYFRA 21-1 is an early predictor of chemotherapeutic effectiveness in advanced nonsmall cell lung cancer. Medicine. 95(52). e5748–e5748. 4 indexed citations
16.
Bai, Rongpan, Yu Weng, Liling Su, et al.. (2015). Association of a Pre-miR-27a Polymorphism with Cancer Risk: an Updated Meta-analysis. Asian Pacific Journal of Cancer Prevention. 15(23). 10107–10114. 11 indexed citations
17.
Wang, Gang, Lingyan Zheng, Zhijian Yu, et al.. (2012). Increased cyclin-dependent kinase 6 expression in bladder cancer. Oncology Letters. 4(1). 43–46. 37 indexed citations
18.
Weng, Yu, Liqin Lu, Jìng Guo, et al.. (2012). p53 codon 72 polymorphism and Hematological Cancer Risk: An Update Meta-Analysis. PLoS ONE. 7(9). e45820–e45820. 29 indexed citations
19.
Lu, Liqin. (2011). The discussion of numerical control machine technology of complex curved surface. Manufacturing Automation.
20.
Brown, Brian, et al.. (1996). Modelling of cardiac-related changes in lung resistivity measured with EITS. Physiological Measurement. 17(4A). A227–A234. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026